GeneDx Holdings Corp.

GeneDx Holdings Corp., listed on Nasdaq under ticker CMLF, is a healthcare-focused special purpose acquisition company co-sponsored by Casdin Capital and Churchill Capital that completed its initial public offering in 2020. The company filed an 8-K with the Securities and Exchange Commission on February 11, 2021, during its active search phase for a qualifying business combination within the life sciences and genomic medicine sector. Both sponsoring firms brought specialized healthcare and investment expertise to the vehicle, reflecting the significant wave of SPAC formation targeting precision medicine and genomics during that period. Sign up on SpacDesk for full access to CMLF's complete filing history, sponsor profiles, and deal timeline data.